A multi-index ROC-based methodology for high throughput experiments in gene discovery
暂无分享,去创建一个
[1] R. Farias-Eisner,et al. The Chemistry and Tumoricidal Activity of Nitric Oxide/Hydrogen Peroxide and the Implications to Cell Resistance/Susceptibility (*) , 1996, The Journal of Biological Chemistry.
[2] Marco Muselli,et al. Not proper ROC curves as new tool for the analysis of differentially expressed genes in microarray experiments , 2008, BMC Bioinformatics.
[3] A. Chambers,et al. The Role of Osteopontin in Breast Cancer: Clinical and Experimental Studies , 2001, Journal of Mammary Gland Biology and Neoplasia.
[4] M. F. Fuller,et al. Practical Nonparametric Statistics; Nonparametric Statistical Inference , 1973 .
[5] S. Wingren,et al. Polymorphism in the manganese superoxide dismutase (MnSOD) gene and risk of breast cancer in young women , 2005, Journal of Cancer Research and Clinical Oncology.
[6] B. Wold,et al. p62 overexpression in breast tumors and regulation by prostate-derived Ets factor in breast cancer cells , 2003, Oncogene.
[7] S. Dudoit,et al. Comparison of Discrimination Methods for the Classification of Tumors Using Gene Expression Data , 2002 .
[8] M. Piccart-Gebhart,et al. Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer , 2010, Nature Reviews Clinical Oncology.
[9] N. Nalini,et al. Evidence of oxidative stress in the circulation of ovarian cancer patients. , 2004, Clinica chimica acta; international journal of clinical chemistry.
[10] D. Bamber. The area above the ordinal dominance graph and the area below the receiver operating characteristic graph , 1975 .
[11] John A. Swets,et al. Evaluation of diagnostic systems : methods from signal detection theory , 1982 .
[12] Gary A. Churchill,et al. Analysis of Variance for Gene Expression Microarray Data , 2000, J. Comput. Biol..
[13] Hiroshi Mamitsuka,et al. Selecting features in microarray classification using ROC curves , 2006, Pattern Recognit..
[14] Jian Huang,et al. Regularized binormal ROC method in disease classification using microarray data , 2005, BMC Bioinformatics.
[15] C. Yiannoutsos,et al. Assessment of diagnostic markers by goodness‐of‐fit tests , 2003, Statistics in medicine.
[16] B. Jensen,et al. High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[17] Ralph B. D'Agostino,et al. Goodness-of-Fit-Techniques , 2020 .
[18] M. Schummer,et al. Selecting Differentially Expressed Genes from Microarray Experiments , 2003, Biometrics.
[19] D. McClish. Analyzing a Portion of the ROC Curve , 1989, Medical decision making : an international journal of the Society for Medical Decision Making.
[20] Ian B. Jeffery,et al. Comparison and evaluation of methods for generating differentially expressed gene lists from microarray data , 2006, BMC Bioinformatics.
[21] Michael F. Ochs,et al. Matrix factorisation methods applied in microarray data analysis , 2010, Int. J. Data Min. Bioinform..
[22] Chuhsing Kate Hsiao,et al. Alternative Summary Indices for the Receiver Operating Characteristic Curve , 1996, Epidemiology.
[23] Chris Lloyd,et al. Regression Models for Convex ROC Curves , 2000, Biometrics.
[24] D. Jeong,et al. Selenoprotein W is a glutathione‐dependent antioxidant in vivo , 2002, FEBS letters.
[25] L. Pan,et al. Identification of platinum-resistance associated proteins through proteomic analysis of human ovarian cancer cells and their platinum-resistant sublines. , 2007, Journal of proteome research.
[26] R. Spang,et al. Predicting the clinical status of human breast cancer by using gene expression profiles , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[27] O. Ogawa,et al. Restoration of cyclin D2 has an inhibitory potential on the proliferation of LNCaP cells. , 2009, Biochemical and biophysical research communications.
[28] A. Diamond,et al. Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. , 2003, Cancer research.
[29] M H Gail,et al. A generalization of the one-sided two-sample Kolmogorov-Smirnov statistic for evaluating diagnostic tests. , 1976, Biometrics.
[30] Ming Tan,et al. ROC‐Based Utility Function Maximization for Feature Selection and Classification with Applications to High‐Dimensional Protease Data , 2008, Biometrics.
[31] Elizabeth A. Repasky,et al. VSGP/F-Spondin: A New Ovarian Cancer Marker , 2005, Tumor Biology.
[32] A. Scorilas,et al. Kallikreins as Markers of Disseminated Tumour Cells in Ovarian Cancer – A Pilot Study , 2006, Tumor Biology.
[33] W. Youden,et al. Index for rating diagnostic tests , 1950, Cancer.
[34] Lei Yu,et al. Feature Cluster Selection for High-Throughput Data Analysis , 2007, 2007 IEEE International Conference on Bioinformatics and Biomedicine (BIBM 2007).
[35] Dale H. Mugler,et al. A gene selection method for classifying cancer samples using 1D discrete wavelet transform , 2009, Int. J. Comput. Biol. Drug Des..
[36] X. Cao,et al. Smad1 Interacts with Homeobox DNA-binding Proteins in Bone Morphogenetic Protein Signaling* , 1999, The Journal of Biological Chemistry.
[37] George W. Irwin,et al. Two-stage gene selection for support vector machine classification of microarray data , 2009, Int. J. Model. Identif. Control..
[38] C. Metz,et al. Maximum likelihood estimation of receiver operating characteristic (ROC) curves from continuously-distributed data. , 1998, Statistics in medicine.
[39] J. Johansen,et al. Serum YKL-40: a new potential marker of prognosis and location of metastases of patients with recurrent breast cancer. , 1995, European journal of cancer.
[40] M. Hung,et al. Grb2 downregulation leads to Akt inactivation in heregulin-stimulated and ErbB2-overexpressing breast cancer cells , 2000, Oncogene.
[41] V. Kosma,et al. Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. , 2001, Carcinogenesis.
[42] L. Rodrigues,et al. The Role of Osteopontin in Tumor Progression and Metastasis in Breast Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.